Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Malignant Neoplasm of Peritoneum”

250 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 250 results

Testing effectiveness (Phase 2)Study completedNCT00003670
What this trial is testing

Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Eli Lilly and Company
Early research (Phase 1)Study completedNCT00616941
What this trial is testing

Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Ludwig Institute for Cancer Research 28
Large-scale testing (Phase 3)Not Yet RecruitingNCT07816666
What this trial is testing

Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer

Who this might be right for
Platinum-sensitive Relapsed Epithelial Ovarian CancerPlatinum-sensitive Relapsed Fallopian Tube CancerPlatinum-sensitive Relapsed Primary Peritoneal Cancer
AstraZeneca 600
Large-scale testing (Phase 3)Looking for participantsNCT06824467
What this trial is testing

Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Merck Sharp & Dohme LLC 770
Large-scale testing (Phase 3)Not Yet RecruitingNCT05300945
What this trial is testing

HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy

Who this might be right for
Gastric CancerPeritoneal Metastases
Zhixin Cao 200
Early research (Phase 1)Looking for participantsNCT04811703
What this trial is testing

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer

Who this might be right for
Metastatic Ovarian CarcinomaPeritoneal CarcinomatosisStage III Ovarian Cancer+4 more
Hospices Civils de Lyon 15
Early research (Phase 1)Looking for participantsNCT06912152
What this trial is testing

MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors

Who this might be right for
B7-H3-positive Advanced Malignant Solid Tumors Advanced Primary Peritoneal Tumors or Secondary Abdominal Metastatic Malignant Solid Tumors
Zhejiang University 12
Testing effectiveness (Phase 2)UnknownNCT05030246
What this trial is testing

Trial of Surufatinib Combined With Toripalimab in the Treatment of Peritoneal Metastatic Carcinoma of Gastrointestinal or Primary Peritoneal Cancer

Who this might be right for
Refractory Metastatic Digestive System CarcinomaPrimary Peritoneal Cancer
Peking University 72
Testing effectiveness (Phase 2)Study completedNCT02032485
What this trial is testing

Near-Infrared Imaging of Peritoneal Carcinomatosis From Colorectal Cancer

Who this might be right for
Colorectal CancerPeritoneal Carcinomatosis
Jules Bordet Institute 10
Testing effectiveness (Phase 2)Ended earlyNCT00522301
What this trial is testing

Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Memorial Sloan Kettering Cancer Center 6
Testing effectiveness (Phase 2)Temporarily pausedNCT04042116
What this trial is testing

Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor

Who this might be right for
Advanced Solid TumorGynecologic Cancer
Clovis Oncology, Inc. 227
Not applicableStudy completedNCT05644249
What this trial is testing

PIPAC and FOLFOX for Gastric Cancer Peritoneal Cancer

Who this might be right for
Gastric CancerPeritoneal Carcinomatosis
Vilnius University 37
Not applicableLooking for participantsNCT04907643
What this trial is testing

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Who this might be right for
Cancer PainVisceral PainGastrointestinal Neoplasms+76 more
Cedars-Sinai Medical Center 360
Not applicableUnknownNCT06091683
What this trial is testing

Adjuvant Pressurized Intraperitoneal Aerosol Chemotherapy to Prevent Colorectal Peritoneal Metastases (ProphyPIPAC)

Who this might be right for
Peritoneal Metastases From Colorectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 10
Not applicableStudy completedNCT01826227
What this trial is testing

Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian TubePrimary Peritoneal
Memorial Sloan Kettering Cancer Center 5
Large-scale testing (Phase 3)Active Not RecruitingNCT02758951
What this trial is testing

Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases

Who this might be right for
Colorectal NeoplasmColorectal CancerColorectal Neoplasms Malignant+8 more
Koen Rovers 358
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT02487849
What this trial is testing

HIPEC After Secondary Cytoreductive Operation in Patients With Platinum-sensitive Recurrence of Ovarian Carcinoma

Who this might be right for
Epithelial Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Krankenhaus Barmherzige Schwestern Linz
Not applicableNot Yet RecruitingNCT07474025
What this trial is testing

Integrating Peritoneal Histological Growth Patterns Into Preoperative Decision-Making for Colorectal Peritoneal Metastses

Who this might be right for
Peritoneal (Metastatic) CancerColorectal CancerColorectal (Colon or Rectal) Cancer+1 more
Jules Bordet Institute 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05456685
What this trial is testing

Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer

Who this might be right for
High Grade Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
AbbVie 125
Next Page